EFTA02411986

To: Jeffrey Epsteinfleevacationepgmail.comi Cc: Woodson Merrell From: woodson merrell Sent: Wed 11/24/2010 12:50:03 AM Subject: bacteriophage information Jeffrey, This should qualify as cutting edge research science with tremendous clinical applications, especially for treatment of drug-resistant infections (? and investment potential). Best, Woody http://en.wikipedia.org/wilci/Bacteriophage good description of bacteriophages: history, science, and applications http://www.phageinternational.com/about.htm website of the research company Phage International (assoc with Georgia, Russia lab): (my cousin Wm Jouris is an advisor in this one) http://www.phageinternational.com/ptc.lum about Phage International's collaboration with the clinical center in Georgia currently treating chronic resistant bacterial infections with phages http://www.biochimpharm.ge/content.php?id=15 the main Georgian company doing the research and treatment http://www.phage.com home I html website of US research company Omnilytics (some USDA approved salmonella treatment for cattle) EFTA_R1_01473517 EFTA02411986